Article
Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice.
Scientific reports - 20 Oct 2015
Shih Yao-Ming, Sun Cheng-Pu, Chou Hui-Hsien, Wu Tzu-Hui, Chen Chun-Chi, Wu Ping-Yi, Enya Chen Yu-Chen, Bissig Karl-Dimiter, Tao Mi-Hua
Abstract excerpt
Selection of escape mutants with mutations within the target sequence could abolish the antiviral RNA interference activity. Here, we investigated the impact of a pre-existing shRNA-resistant HBV variant on the efficacy of shRNA therapy. We previously identified a highly potent shRNA, S1, which, when delivered by an adeno-associated viral vector, effectively inhibits HBV replication in HBV transgenic mice. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
